{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:31:18Z","timestamp":1788496278557,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/03951-2"],"award-info":[{"award-number":["2021\/03951-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/03951-2"],"award-info":[{"award-number":["2021\/03951-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["408680\/2021-0"],"award-info":[{"award-number":["408680\/2021-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11154-025-09953-w","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T15:54:43Z","timestamp":1740585283000},"page":"279-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Melatonin administration on bone properties of animals under hypoestrogenism: A systematic review"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5074-6263","authenticated-orcid":false,"given":"Taciane Maria Melges","family":"Pejon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8324-8866","authenticated-orcid":false,"given":"Leonardo Henrique Dalcheco","family":"Messias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8106-4791","authenticated-orcid":false,"given":"Rafael Henrique","family":"de Oliveira Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5096-5189","authenticated-orcid":false,"given":"Vanessa","family":"Bertolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1228-9967","authenticated-orcid":false,"given":"Andr\u00e9 Felipe","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7176-2713","authenticated-orcid":false,"given":"Wladimir Rafael","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"9953_CR1","doi-asserted-by":"publisher","unstructured":"Critchlow AJ, et al. The role of estrogen in female skeletal muscle aging: A systematic review. Maturitas. 2023. https:\/\/doi.org\/10.1016\/j.maturitas.2023.107844.","DOI":"10.1016\/j.maturitas.2023.107844"},{"key":"9953_CR2","doi-asserted-by":"publisher","unstructured":"Medina-Contreras JML, et al. Ovariectomized rodents as a menopausal metabolic syndrome model. A minireview. Mol Cell Biochem. 2020. https:\/\/doi.org\/10.1007\/s11010-020-03879-4.","DOI":"10.1007\/s11010-020-03879-4"},{"key":"9953_CR3","doi-asserted-by":"publisher","unstructured":"Zuo Q, et al. Pathway preferential estrogens prevent hepatosteatosis due to ovariectomy and high-fat diets. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13103334.","DOI":"10.3390\/nu13103334"},{"key":"9953_CR4","doi-asserted-by":"publisher","unstructured":"Baxi D, et al. Melatonin supplementation therapy as a potent alternative to ERT in ovariectomized rats. Climacteric. 2012. https:\/\/doi.org\/10.3109\/13697137.2011.618565.","DOI":"10.3109\/13697137.2011.618565."},{"key":"9953_CR5","doi-asserted-by":"publisher","unstructured":"Steiner BM, Berry DC. The regulation of adipose tissue health by estrogens. Front Endocrinol. 2022. https:\/\/doi.org\/10.3389\/fendo.2022.889923.","DOI":"10.3389\/fendo.2022.889923"},{"key":"9953_CR6","doi-asserted-by":"publisher","unstructured":"Pejon TMM, et al. Effect of 12-wk training in ovariectomised rats on PGC-1\u03b1, NRF-1 and energy substrates. Int J Sports Med. 2022. https:\/\/doi.org\/10.1055\/a-1717-1693.","DOI":"10.1055\/a-1717-1693"},{"key":"9953_CR7","doi-asserted-by":"publisher","unstructured":"Pejon TMM, et al. Effects of moderate\u2013intensity physical training on skeletal muscle substrate transporters and metabolic parameters of ovariectomized rats. Metabolites. 2022. https:\/\/doi.org\/10.3390\/metabo12050402.","DOI":"10.3390\/metabo12050402"},{"key":"9953_CR8","doi-asserted-by":"publisher","unstructured":"Ozturk S, et al. Resveratrol prevents ovariectomy-induced bone quality deterioration by improving the microarchitectural and biophysicochemical properties of bone. J Bone Miner Metab. 2023. https:\/\/doi.org\/10.1007\/s00774-023-01416-z.","DOI":"10.1007\/s00774-023-01416-z"},{"key":"9953_CR9","doi-asserted-by":"publisher","unstructured":"Lin Z, et al. Leptin and melatonin\u2019s effects on OVX rodents\u2019 bone metabolism. Front Endocrinol. 2023. https:\/\/doi.org\/10.3389\/fendo.2023.1185476.","DOI":"10.3389\/fendo.2023.1185476"},{"key":"9953_CR10","doi-asserted-by":"publisher","unstructured":"Li T, et al Daytime administration of melatonin has better protective effects on bone loss in ovariectomized rats. J Orthop. 2023. https:\/\/doi.org\/10.1186\/s13018-023-03695-8.","DOI":"10.1186\/s13018-023-03695-8"},{"key":"9953_CR11","doi-asserted-by":"publisher","unstructured":"Guan H, et al. Melatonin increases bone mass in normal, perimenopausal, and postmenopausal osteoporotic rats via the promotion of osteogenesis. J Transl Med. 2022. https:\/\/doi.org\/10.1186\/s12967-022-03341-7.","DOI":"10.1186\/s12967-022-03341-7"},{"key":"9953_CR12","doi-asserted-by":"publisher","unstructured":"Bao T et al. Can melatonin improve the osteopenia of perimenopausal and postmenopausal women? A meta-analysis. Int J Endocrinol. 2019. https:\/\/doi.org\/10.1155\/2019\/5151678.","DOI":"10.1155\/2019\/5151678"},{"key":"9953_CR13","unstructured":"Office of the Surgeon General (US). Bone Health and Osteoporosis: a report of the surgeon general. Rockville (MD): Office of the Surgeon General (US); 2004. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK45513\/."},{"key":"9953_CR14","doi-asserted-by":"publisher","unstructured":"Gao S, Zhao Y. Quality of life in postmenopausal women with osteoporosis: a systematic review and meta-analysis. Qual Life Res. 2023. https:\/\/doi.org\/10.1007\/s11136-022-03281-1.","DOI":"10.1007\/s11136-022-03281-1"},{"key":"9953_CR15","doi-asserted-by":"publisher","unstructured":"Yang Z, et al. Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis. Gynecol Endocrinol. 2017. https:\/\/doi.org\/10.1080\/09513590.2016.1248932.","DOI":"10.1080\/09513590.2016.1248932"},{"key":"9953_CR16","doi-asserted-by":"publisher","unstructured":"Shufelt CL, Manson JE. Menopausal hormone therapy and cardiovascular disease: the role of formulation, dose, and route of delivery. J Clin Endocrinol Metab. 2021. https:\/\/doi.org\/10.1210\/clinem\/dgab042.","DOI":"10.1210\/clinem\/dgab042"},{"key":"9953_CR17","doi-asserted-by":"publisher","unstructured":"Hardeland R. Aging, melatonin, and the pro-and anti-inflammatory networks. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20051223.","DOI":"10.3390\/ijms20051223"},{"key":"9953_CR18","doi-asserted-by":"publisher","unstructured":"Borges LS, et al. Melatonin decreases muscular oxidative stress and inflammation induced by strenuous exercise and stimulates growth factor synthesis. J Pineal Res. 2015. https:\/\/doi.org\/10.1111\/jpi.12202.","DOI":"10.1111\/jpi.12202"},{"key":"9953_CR19","doi-asserted-by":"publisher","unstructured":"Cipolla\u2010Neto J, et al. Melatonin, energy metabolism, and obesity: a review. J Pineal Res. 2014. https:\/\/doi.org\/10.1111\/jpi.12137.","DOI":"10.1111\/jpi.12137"},{"key":"9953_CR20","doi-asserted-by":"publisher","unstructured":"Bagherifard A, et al. Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects. Osteoporosis Int. 2023. https:\/\/doi.org\/10.1007\/s00198-023-06836-1.","DOI":"10.1007\/s00198-023-06836-1"},{"key":"9953_CR21","doi-asserted-by":"publisher","unstructured":"Amstrup AK, et al. MelatoSnin and the skeleton.\u00a0Osteoporosis Int. 2013. https:\/\/doi.org\/10.1007\/s00198-013-2404-8.","DOI":"10.1007\/s00198-013-2404-8"},{"key":"9953_CR22","doi-asserted-by":"publisher","unstructured":"Choi JH, et al. Melatonin inhibits osteoclastogenesis and bone loss in ovariectomized mice by regulating PRMT1-Mediated signaling. Endocrinology. 2021. https:\/\/doi.org\/10.1210\/endocr\/bqab057.","DOI":"10.1210\/endocr\/bqab057"},{"key":"9953_CR23","doi-asserted-by":"publisher","unstructured":"Malakoti F, et al. The role of melatonin in bone regeneration: A review of involved signaling pathways. Biochimie. 2022. https:\/\/doi.org\/10.1016\/j.biochi.2022.08.008.","DOI":"10.1016\/j.biochi.2022.08.008"},{"key":"9953_CR24","doi-asserted-by":"publisher","unstructured":"Munmun F, et al. The role of MEK1\/2 and MEK5 in melatonin\u2010mediated actions on osteoblastogenesis, osteoclastogenesis, bone microarchitecture, biomechanics, and bone formation. J Pineal Res. 2022. https:\/\/doi.org\/10.1111\/jpi.12814.","DOI":"10.1111\/jpi.12814"},{"key":"9953_CR25","doi-asserted-by":"publisher","unstructured":"Macdonald IJ, et al. Melatonin inhibits osteoclastogenesis and osteolytic bone metastasis: implications for osteoporosis.\u00a0Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22179435.","DOI":"10.3390\/ijms22179435"},{"key":"9953_CR26","doi-asserted-by":"publisher","unstructured":"Yeleswaram K, et al. Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications.\u00a0J Pineal Res. 1997, https:\/\/doi.org\/10.1111\/j.1600-079X.1997.tb00302.x.","DOI":"10.1111\/j.1600-079X.1997.tb00302.x"},{"key":"9953_CR27","doi-asserted-by":"publisher","unstructured":"Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone remodeling. J Biol Chem. 2010. https:\/\/doi.org\/10.1074\/jbc.R109.041087.","DOI":"10.1074\/jbc.R109.041087"},{"key":"9953_CR28","doi-asserted-by":"publisher","unstructured":"Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"9953_CR29","unstructured":"Akers J (2009) Systematic Reviews: CRD\u2019s Guidance for Undertaking Reviews in Health Care. York, UK: CRD, University of York."},{"key":"9953_CR30","doi-asserted-by":"publisher","unstructured":"Hooijmans CR, et al (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC medical research methodology. 2014. https:\/\/doi.org\/10.1186\/1471-2288-14-43.","DOI":"10.1186\/1471-2288-14-43"},{"key":"9953_CR31","doi-asserted-by":"publisher","unstructured":"Higgins JP, et al. The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343. https:\/\/doi.org\/10.1136\/bmj.d5928.","DOI":"10.1136\/bmj.d5928"},{"key":"9953_CR32","unstructured":"Ahmed HH, et al. Efficacy of newly synthesized melatonin derivatives as antiosteoporotic agents in ovariectomized rats. J Appl Sci Res. 2009."},{"key":"9953_CR33","doi-asserted-by":"publisher","unstructured":"G\u00fcrler EB, et al. Melatonin supports alendronate in preserving bone matrix and prevents gastric inflammation in ovariectomized rats.\u00a0Cell Biochem Funct. 2019. https:\/\/doi.org\/10.1002\/cbf.3379.","DOI":"10.1002\/cbf.3379"},{"key":"9953_CR34","doi-asserted-by":"publisher","unstructured":"Sun T, et al. Melatonin improves the osseointegration of hydroxyapatite-coated titanium implants in senile female rats. Z Gerontol Geriatri. 2020. https:\/\/doi.org\/10.1007\/s00391-019-01640-1.","DOI":"10.1007\/s00391-019-01640-1"},{"key":"9953_CR35","doi-asserted-by":"publisher","unstructured":"Tao ZS, et al. Rapamycin could increase the effects of melatonin against age-dependent bone loss. Z Gerontol Geriatri. 2020. https:\/\/doi.org\/10.1007\/s00391-019-01659-4.","DOI":"10.1007\/s00391-019-01659-4"},{"key":"9953_CR36","doi-asserted-by":"publisher","unstructured":"Zhou W, et al. Melatonin increases bone mass around the prostheses of OVX Rats by ameliorating mitochondrial oxidative stress via the SIRT3\/SOD2 signaling pathway. Oxid Med Cell Longev. 2019. https:\/\/doi.org\/10.1155\/2019\/4019619.","DOI":"10.1155\/2019\/4019619"},{"key":"9953_CR37","doi-asserted-by":"publisher","unstructured":"Zhou MS, Tao ZS. Systemic administration with melatonin in the daytime has a better effect on promoting osseointegration of titanium rods in ovariectomized rats. Bone Jt Res. 2022. https:\/\/doi.org\/10.1155\/2019\/4019619.","DOI":"10.1155\/2019\/4019619"},{"key":"9953_CR38","doi-asserted-by":"publisher","unstructured":"Chen W, et al. Melatonin restores the osteoporosis-impaired osteogenic potential of bone marrow mesenchymal stem cells by preserving SIRT1-mediated intracellular antioxidant properties. Free Radic Biol Med. 2020. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.10.412.","DOI":"10.1016\/j.freeradbiomed.2019.10.412"},{"key":"9953_CR39","doi-asserted-by":"publisher","unstructured":"Chen W, et al. Melatonin improves the resistance of oxidative stress-induced cellular senescence in osteoporotic bone marrow mesenchymal stem cells. Oxid Med Cell Longev. 2022. https:\/\/doi.org\/10.1155\/2022\/7420726.","DOI":"10.1155\/2022\/7420726"},{"key":"9953_CR40","doi-asserted-by":"publisher","unstructured":"Liu H, Yang M. Melatonin alleviates hydrogen peroxide induced oxidative damage in MC3T3-E1 cells via SIRT1\/p66SHC pathway and promotes osteogenesis. Free Radic Res. 2021. https:\/\/doi.org\/10.1080\/10715762.2022.2037580.","DOI":"10.1080\/10715762.2022.2037580"},{"key":"9953_CR41","doi-asserted-by":"publisher","unstructured":"Zheng S, et al. Melatonin accelerates osteoporotic bone defect repair by promoting osteogenesis\u2013angiogenesis coupling. Front Endocrinol. 2022. https:\/\/doi.org\/10.3389\/fendo.2022.826660.","DOI":"10.3389\/fendo.2022.826660"},{"key":"9953_CR42","doi-asserted-by":"publisher","unstructured":"Huang X, et al. Melatonin suppresses bone marrow adiposity in ovariectomized rats by rescuing the imbalance between osteogenesis and adipogenesis through SIRT1 activation. J Orthop Transl. 2023. https:\/\/doi.org\/10.1016\/j.jot.2022.10.002.","DOI":"10.1016\/j.jot.2022.10.002"},{"key":"9953_CR43","doi-asserted-by":"publisher","unstructured":"Ladizesky MG, et al. Effect of melatonin on bone metabolism in ovariectomized rats. Life Sci. 2001. https:\/\/doi.org\/10.1016\/S0024-3205(01)01431-X.","DOI":"10.1016\/S0024-3205(01)01431-X"},{"key":"9953_CR44","doi-asserted-by":"publisher","unstructured":"Ladizesky MG, et al. Melatonin increases oestradiol\u2010induced bone formation in ovariectomized rats. J Pineal Res. 2003. https:\/\/doi.org\/10.1034\/j.1600-079X.2003.00021.x.","DOI":"10.1034\/j.1600-079X.2003.00021.x"},{"key":"9953_CR45","unstructured":"Ostrowska Z, et al. The influence of pinealectomy and melatonin administration on the dynamic pattern of biochemical markers of bone metabolism in experimental osteoporosis in the rat. Neuroendocrinology. 2002."},{"key":"9953_CR46","doi-asserted-by":"publisher","unstructured":"Oktem G, et al. Evaluation of the relationship between inducible nitric oxide synthase (iNOS) activity and effects of melatonin in experimental osteoporosis in the rat. Surg Radiol Anat. 2006. https:\/\/doi.org\/10.1007\/s00276-005-0065-9.","DOI":"10.1007\/s00276-005-0065-9"},{"key":"9953_CR47","unstructured":"Uslu S, et al. Constructive effect of exogenous melatonin against osteoporosis after ovariectomy in rats. Anal Quant Cytol Histol. 2007."},{"key":"9953_CR48","doi-asserted-by":"publisher","unstructured":"Murat \u00d6, \u00d6nder \u00c7. The effects of exogenous melatonin administration on bone in ovariectomized and pinealectomized rats. Clin Exp Obstet Gynecol. 2019. https:\/\/doi.org\/10.12891\/ceog4941.2019.","DOI":"10.12891\/ceog4941.2019"},{"key":"9953_CR49","doi-asserted-by":"publisher","unstructured":"Sharan K, et al. Regulation of bone mass through pineal\u2010derived melatonin\u2010MT2 receptor pathway. J Pineal Res. 2017. https:\/\/doi.org\/10.1111\/jpi.12423.","DOI":"10.1111\/jpi.12423"},{"key":"9953_CR50","doi-asserted-by":"publisher","unstructured":"Xu L, et al. Melatonin suppresses estrogen deficiency-induced osteoporosis and promotes osteoblastogenesis by inactivating the NLRP3 inflammasome. Calcif Tissue Int. 2018. https:\/\/doi.org\/10.1007\/s00223-018-0428-y.","DOI":"10.1007\/s00223-018-0428-y"},{"key":"9953_CR51","doi-asserted-by":"publisher","unstructured":"Da W, et al. Protective role of melatonin against postmenopausal bone loss via enhancement of citrate secretion from osteoblasts. Front Pharmacol. 2020. https:\/\/doi.org\/10.3389\/fphar.2020.00667.","DOI":"10.3389\/fphar.2020.00667"},{"key":"9953_CR52","doi-asserted-by":"publisher","unstructured":"Zhou Y, et al. Melatonin up\u2010regulates bone marrow mesenchymal stem cells osteogenic action but suppresses their mediated osteoclastogenesis via MT 2 \u2010inactivated NF\u2010\u03baB pathway. Br J Pharmacol. 2020. https:\/\/doi.org\/10.1111\/bph.14972.","DOI":"10.1111\/bph.14972"},{"key":"9953_CR53","doi-asserted-by":"publisher","unstructured":"Huang J, et al. Combined effects of low-frequency pulsed electromagnetic field and melatonin on ovariectomy-induced bone loss in mice. Bioelectromagnetics. 2021. https:\/\/doi.org\/10.1002\/bem.22372.","DOI":"10.1002\/bem.22372"},{"key":"9953_CR54","doi-asserted-by":"publisher","unstructured":"Farlay D, et al. Bone remodeling and bone matrix quality before and after menopause in healthy women.\u00a0Bone. 2019. https:\/\/doi.org\/10.1016\/j.bone.2019.08.003.","DOI":"10.1016\/j.bone.2019.08.003"},{"key":"9953_CR55","doi-asserted-by":"publisher","unstructured":"Wang L, et al. Mechanical regulation of bone remodeling.\u00a0Bone Res. 2022. https:\/\/doi.org\/10.1038\/s41413-022-00190-4.","DOI":"10.1038\/s41413-022-00190-4"},{"key":"9953_CR56","doi-asserted-by":"publisher","unstructured":"Taylor JG, Bushinsky DA. Calcium and phosphorus homeostasis.\u00a0Blood Purif. 2009. https:\/\/doi.org\/10.1159\/000209740.","DOI":"10.1159\/000209740"},{"key":"9953_CR57","doi-asserted-by":"publisher","unstructured":"Vimalraj S. Alkaline phosphatase: Structure, expression and its function in bone mineralization.\u00a0Gene. 2020. https:\/\/doi.org\/10.1016\/j.gene.2020.144855.","DOI":"10.1016\/j.gene.2020.144855"},{"key":"9953_CR58","doi-asserted-by":"publisher","unstructured":"Andersen LPH, et al. The safety of melatonin in humans.\u00a0Clin Drug Investig. 2016. https:\/\/doi.org\/10.1007\/s40261-015-0368-5.","DOI":"10.1007\/s40261-015-0368-5"},{"key":"9953_CR59","doi-asserted-by":"publisher","unstructured":"Treister-Goltzman Y, Peleg R. Melatonin and the health of menopausal women: a systematic review.\u00a0J Pineal Res. 2021. https:\/\/doi.org\/10.1111\/jpi.12743.","DOI":"10.1111\/jpi.12743"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09953-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-025-09953-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09953-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T05:06:08Z","timestamp":1742274368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-025-09953-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["9953"],"URL":"https:\/\/doi.org\/10.1007\/s11154-025-09953-w","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"17 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}